Charles River Laboratories to Present at UBS and Jefferies Conferences
Charles River Laboratories (NYSE: CRL) has announced its upcoming presentations at two major healthcare conferences. The company will present at the UBS Global Healthcare Conference on November 12th at 10:15 a.m. PT and the Jefferies London Healthcare Conference on November 20th at 2:00 p.m. GMT.
Management will discuss the company's strategic focus, business developments, and recent trends. Both presentations will be available via live webcast through the Investor Relations section of Charles River's website, with replays accessible for at least two weeks afterward.
Charles River Laboratories (NYSE: CRL) ha annunciato le sue prossime presentazioni a due importanti conferenze sanitarie. L'azienda presenterà alla UBS Global Healthcare Conference il 12 novembre alle 10:15 PT e alla Jefferies London Healthcare Conference il 20 novembre alle 14:00 GMT.
La direzione discuterà il focus strategico dell'azienda, gli sviluppi commerciali e le tendenze recenti. Entrambe le presentazioni saranno disponibili tramite live webcast nella sezione Relazioni con gli Investitori del sito web di Charles River, con registrazioni accessibili per almeno due settimane dopo.
Charles River Laboratories (NYSE: CRL) ha anunciado sus próximas presentaciones en dos importantes conferencias de salud. La empresa presentará en la UBS Global Healthcare Conference el 12 de noviembre a las 10:15 a.m. PT y en la Jefferies London Healthcare Conference el 20 de noviembre a las 2:00 p.m. GMT.
La dirección discutirá el enfoque estratégico de la empresa, los desarrollos comerciales y las tendencias recientes. Ambas presentaciones estarán disponibles a través de una transmisión en vivo en la sección de Relaciones con Inversores del sitio web de Charles River, con repeticiones accesibles durante al menos dos semanas después.
찰스 리버 실험실 (NYSE: CRL)는 두 개의 주요 의료 컨퍼런스에서의 발표를 알렸습니다. 이 회사는 UBS 글로벌 헬스케어 컨퍼런스에서 11월 12일 오전 10:15 PT와 제퍼리즈 런던 헬스케어 컨퍼런스에서 11월 20일 오후 2:00 GMT에 발표할 예정입니다.
경영진은 회사의 전략적 초점, 비즈니스 개발 및 최근 동향을 논의할 것입니다. 두 개의 발표는 찰스 리버 웹사이트의 투자자 관계 섹션을 통해 생중계되며, 이후 최소 2주 동안 다시 보기할 수 있습니다.
Charles River Laboratories (NYSE: CRL) a annoncé ses prochaines présentations lors de deux grandes conférences sanitaires. L'entreprise présentera à la UBS Global Healthcare Conference le 12 novembre à 10h15 PT et à la Jefferies London Healthcare Conference le 20 novembre à 14h00 GMT.
La direction discutera de l'orientation stratégique de l'entreprise, des développements commerciaux et des tendances récentes. Les deux présentations seront disponibles en direct via un webcast dans la section Relations avec les Investisseurs du site web de Charles River, avec des rediffusions accessibles pendant au moins deux semaines après.
Charles River Laboratories (NYSE: CRL) hat seine bevorstehenden Präsentationen auf zwei bedeutenden Gesundheitskonferenzen angekündigt. Das Unternehmen wird am 12. November um 10:15 Uhr PT auf der UBS Global Healthcare Conference und am 20. November um 14:00 Uhr GMT auf der Jefferies London Healthcare Conference präsentieren.
Das Management wird den strategischen Fokus des Unternehmens, Geschäftsentwicklungen und aktuelle Trends besprechen. Beide Präsentationen sind über einen Live-Stream in der Rubrik Investor Relations auf der Website von Charles River verfügbar, mit Aufzeichnungen, die mindestens zwei Wochen lang zugänglich sind.
- None.
- None.
Management will provide an overview of Charles River’s strategic focus, business developments, and recent trends.
A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111508820/en/
Investor Relations Contact:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.
FAQ
When is Charles River Laboratories (CRL) presenting at the UBS Global Healthcare Conference?
What time is Charles River Laboratories (CRL) presenting at the Jefferies London Healthcare Conference?
How can investors access Charles River Laboratories (CRL) conference presentations?
What topics will Charles River Laboratories (CRL) cover in their conference presentations?
